Skip to content
Homepage
Category:
Time Sensitive
Posted Date:
June 6, 2026
John Jae Woo Lee Named Top Technical Leader of the Decade and one of the Top 25 Global Impact Leaders by IAOTP
Written By: EIN Presswire
June 6, 2026
Best Mortgage Lenders for Bad Credit in June 2026
Written By: EIN Presswire
June 6, 2026
Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association’s 2026 Scientific Sessions
NOVO NORDISK INC.
June 6, 2026
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET
New to The Street
June 6, 2026
NHU Receives Multiple Honors at the Launch Ceremony of Shaoxing’s 2026 Love Enterprise Action Campaign
Lingrong Culture
June 6, 2026
1952 Topps Mickey Mantle, Rare Stanley Cup Card, and Gretzky Rookie Lead $678,750 Miller & Miller Sports Auction
Written By: EIN Presswire
June 6, 2026
New to The Street Signs One-Year National Media Series with Big Sky Industrial (NASDAQ:BSIN), Highlighting America’s Emerging Helium and Carbon Infrastructure Opportunity
New to The Street
June 6, 2026
People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data
Novo Nordisk
June 6, 2026
Dr. Simon S. Rabinowitz Named Top Pediatric Gastroenterologist of the Year by IAOTP
Written By: EIN Presswire
June 6, 2026
H.E Dame Heather McWilliam Selected for The Empowered Woman Award by IAOTP
Written By: EIN Presswire
June 6, 2026
Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
AMERICAN DIABETES ASSOCIATION
June 6, 2026
Fai Chan Selected as Top Aromatherapist of the Year by IAOTP
Written By: EIN Presswire
June 6, 2026
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress
Cullinan Therapeutics, Inc.
June 6, 2026
RuPaul’s Drag Race Runner-Up Lady Camden Headlining LA’s Sober Pride Celebration
NewsNetwork
June 6, 2026
Spring Storm Season Drives Demand for Stormwater Management and Drainage Solutions Across Central PA
JDI Site Solutions
June 5, 2026
Investor Notice: Robbins LLP Informs Investors of the PicS N.V. Class Action
Business Wire
June 5, 2026
Command the Clone Wars’™ Most Cunning Operatives in Star Wars Zero Company™, Launching August 27
Business Wire
June 5, 2026
DropPR Launches Direct-to-Consumer Press and Amplification Service Built for Performance Marketing
Droppr AI Research Desk
June 5, 2026
Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
Ractigen Therapeutics
June 5, 2026
OrsoBio to Present Preclinical and Clinical Data from its Mitochondrial Protonophore Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
Business Wire
June 5, 2026
Verdiva Bio Presents Preclinical Data on Investigational Obesity Drug Candidates at the American Diabetes Association 86th Scientific Sessions
Business Wire
June 5, 2026
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
Biomea Fusion, Inc.
June 5, 2026
DentaQuest Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
Edelson Lechtzin LLP
June 5, 2026
Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor Partial Agonism
Oban BioPharma, Inc.
June 5, 2026
Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
S&P Dow Jones Indices
June 5, 2026
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
AMERICAN DIABETES ASSOCIATION
June 5, 2026
Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
Precision Diabetes, Inc.
June 5, 2026
Prev
1
…
422
423
424
